3,3'-((Thiophen-2-ylmethyl)azanediyl)bis(1,1,1-trifluoropropan-2-ol)

Catalog No. :
ACLVNB159
CAS No. :
478081-22-0
Molecular Formula :
C11H13F6NO2S
Molecular Weight :
337.29

IUPAC Name:3,3'-((thiophen-2-ylmethyl)azanediyl)bis(1,1,1-trifluoropropan-2-ol)

3,3'-((Thiophen-2-ylmethyl)azanediyl)bis(1,1,1-trifluoropropan-2-ol) structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$494.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3,3'-((Thiophen-2-ylmethyl)azanediyl)bis(1,1,1-trifluoropropan-2-ol)
IUPAC Name3,3'-((thiophen-2-ylmethyl)azanediyl)bis(1,1,1-trifluoropropan-2-ol)
MDL No.MFCD01871702
Molecular FormulaC11H13F6NO2S
Molecular Weight337.29
SMILESOC(CN(CC1=CC=CS1)CC(O)C(F)(F)F)C(F)(F)F
InChI KeyBYTZSGCYBPMHOF-UHFFFAOYSA-N
Synonym1,1,1-TRIFLUORO-3-[(2-THIENYLMETHYL)(3,3,3-TRIFLUORO-2-HYDROXYPROPYL)AMINO]-2-PROPANOL;2-Propanol, 1,1'-[(2-thienylmethyl)imino]bis[3,3,3-trifluoro-
CAS No.478081-22-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACLVNB159 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACOYPU809 route compound structure diagram
    ACOYPU80998-03-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLVNB159 route product structure diagram
    ACLVNB159478081-22-0
Inquiry

2. ACLVNB159 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACUMCW387 route compound structure diagram
    ACUMCW387431-34-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLVNB159 route product structure diagram
    ACLVNB159478081-22-0
Inquiry

Comments (0)